Published 1 year ago • loading... • Updated 1 year ago
Hikma Pledges $1 Billion to Expand US Generic Drug Production: Major Boost for Domestic Healthcare Supply
Summary by stocktitan.net
5 Articles
5 Articles
Hikma Pharmaceuticals USA announces $1 Billion of new US investment to further expand its domestic manufacturing and development of essential generic medicines
Next phase builds on 34+ years of serving the needs of US patients and healthcare providers
Hikma Pledges $1 Billion to Expand US Generic Drug Production: Major Boost for Domestic Healthcare Supply
Hikma's $1B investment expands US-made generic medicines production across 4 states. New facilities will boost annual capacity beyond 12 billion doses. Learn expansion details.
Coverage Details
Total News Sources5
Leaning Left0Leaning Right0Center2Last Updated100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium

